Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

151

Full text

119

Free full text

Publication Types

Journal Article

152

Review

Research Support, Non-U.S. Gov't

Clinical Trial

Clinical Trial, Phase II

Case Reports

Randomized Controlled Trial

Research Support, N.I.H., Extramural

Multicenter Study

Comparative Study

Research Support, U.S. Gov't, P.H.S.

Clinical Trial, Phase I

Clinical Trial, Phase III

Meta-Analysis

Systematic Review

Letter

Editorial

Comment

Evaluation Study

Historical Article

Clinical Trial, Phase IV

Observational Study

Network Meta-Analysis

Controlled Clinical Trial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Imatinib Mesylate""[mesh_terms]

156 Results

Searching titles within these results

A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor.

Eytan Ben Ami, George D Demetri

Expert opinion on drug safety 2016;15(4):571-8

Full Text

Abstract

Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.

C Errani, Y Tanaka, Y Tanaka, A F Mavrogenis, T Takahama, S Tsukamoto

Musculoskeletal surgery 2023;107(1):7-18

Full Text

Abstract

A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?

Jingyang Su, Shengyou Lin, Jiang Yan, Menglei Wang, Jialin Zhang, Jinhua Lu

Current opinion in oncology 2023;35(2):132-144

Full Text

Abstract

Safety and efficacy of Vitamin D supplementation with Imatinib in Chronic Phase- Chronic Myeloid Leukaemia: an Exploratory Randomized Controlled Trial.

Debranjani Chattopadhyay, Shailendra Handu, Sudeep Vaniyath, Anamika Bakliwal, Rituparna Chetia, Uttam Kumar Nath, Puneet Dhamija, Sarika Palepu, Arkapal Bandyopadhyay

BMJ open 2023;13(8):e066361

Free Full Text

Abstract

Conformational landscape and low lying excited states of imatinib.

Emil Vinţeler, Nicoleta-Florina Stan, Raluca Luchian, Călin Căinap, João P Prates Ramalho, Vasile Chiş

Journal of molecular modeling 2015;21(4):84

Full Text

Abstract

Leukemic arthritis and severe hypercalcemia in a man with chronic myeloid leukemia: a case report and review of the literature.

Sirinart Sirinvaravong, Voraparee Suvannarerg, Pongprueth Rujirachun, Apichaya Junyavoraluk, Weerapat Owattanapanich

Journal of medical case reports 2019;12(1):257

Free Full Text

Abstract

Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors.

Jeffrey D Rytlewski, Jean-Yves Blay, Rebecca A Gladdy, Breelyn A Wilky, Adam M Fontebasso

Surgical oncology clinics of North America 2024;33(2):387-408

Full Text

Abstract

Cross Talk between β Cells and Immune Cells: What We Know, What We Think We Know, and What We Should Learn.

Capucine Holtzmann, Roberto Mallone, Fatoumata Samassa

Cold Spring Harbor perspectives in medicine 2025;15(6):

Full Text

Abstract

Cumulative mechanism of several major imatinib-resistant mutations in Abl kinase.

Dorothee Kern, Warintra Pitsawong, Marc Hoemberger

Proceedings of the National Academy of Sciences of the United States of America 2020;117(32):19221-19227

Free Full Text

Abstract

Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment.

Sofia Lampaki, Konstantinos Zarogoulidis, J Francis Turner, Qiang Li, Haidong Huang, Konstantinos Syrigos, Stylianos Kakolyris, Wolfgang Hohenforst-Schmidt, Theodora Tsiouda, Antonis Papaiwannou, Konstantinos Porpodis, John Organtzis, Ioannis Kioumis, Dimitris Petridis, Paul Zarogoulidis, Georgia Pitsiou

Drug design, development and therapy 2015;8():1753-63

Free Full Text

Abstract

An overview of targeted treatments in cancer.

Toni Choueiri, Tarek Mekhail, Carlos Alemany, Rony Abou-Jawde

Clinical therapeutics 2004;25(8):2121-37

Full Text

Abstract

Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study.

Silvia Agarbati, Chiara Paolini, Devis Benfaremo, Matteo Mozzicafreddo, Silvia Svegliati Baroni, Gianluca Moroncini

International journal of molecular sciences 2023;24(11):9623

Free Full Text

Abstract

Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis.

Emanuele Rinninella, Marco Cintoni, Pauline Raoul, Francesca Romana Ponziani, Maurizio Pompili, Carmelo Pozzo, Antonia Strippoli, Emilio Bria, Giampaolo Tortora, Antonio Gasbarrini, Maria Cristina Mele

Internal and emergency medicine 2021;16(5):1341-1356

Free Full Text

Abstract

Emerging strategies for the treatment of mutant Bcr-Abl T315I myeloid leukemia.

John M Goldman, Tariq I Mughal

Clinical lymphoma & myeloma 2007;7 Suppl 2():S81-4

Full Text

Abstract

Clinical resistance to imatinib: mechanisms and implications.

Timothy Hughes, Andreas Hochhaus

Hematology/oncology clinics of North America 2004;18(3):641-56, ix

Full Text

Abstract

Results: 1 – 15 / 156

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Imatinib Mesylate""[mesh_terms]

A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor.

Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.

A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?

Safety and efficacy of Vitamin D supplementation with Imatinib in Chronic Phase- Chronic Myeloid Leukaemia: an Exploratory Randomized Controlled Trial.

Conformational landscape and low lying excited states of imatinib.

Leukemic arthritis and severe hypercalcemia in a man with chronic myeloid leukemia: a case report and review of the literature.

Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors.

Cross Talk between β Cells and Immune Cells: What We Know, What We Think We Know, and What We Should Learn.

Cumulative mechanism of several major imatinib-resistant mutations in Abl kinase.

Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment.

An overview of targeted treatments in cancer.

Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study.

Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis.

Emerging strategies for the treatment of mutant Bcr-Abl T315I myeloid leukemia.

Clinical resistance to imatinib: mechanisms and implications.

Results for
""Imatinib Mesylate""[mesh_terms]